Sort
141,003 grants matching “cytokine”
Regulatory B Cells in the Amelioration of Immune-Mediated Periodontal Disease
$679,177Xiaozhe Han · Ada Forsyth Institute, Inc. · R01 · FY2021 · DE
Targeting Macrophages in Aging SIV-Infected Rhesus Macaques
$679,151Marcelo J Kuroda · University Of California At Davis · R01 · FY2020 · HL
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury
$679,062Timothy Daniel O'Connell · University Of Minnesota · R01 · FY2022 · HL
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury
$679,062Timothy Daniel O'Connell · University Of Minnesota · R01 · FY2023 · HL
Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes
$679,061Kevan C Herold · Yale University · R01 · FY2022 · DK
Mechanistic and Therapeutic Role of the TLR4 Signaling Pathway in Type 1 Diabetes
$679,054William M Ridgway · University Of California At Davis · R01 · FY2025 · DK
Arkansas Integrative Metabolic Research Center
$679,042Kyle Patrick Quinn · University Of Arkansas At Fayetteville · P20 · FY2024 · GM
Mechanisms of Fibrosis in Asthma and Other Fibroproliferative Diseases
$679,026Thomas Wynn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Collective Responses to Malaria Vaccination
$679,001Kenneth D Stuart · Seattle Children'S Hospital · U01 · FY2025 · AI
Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B
$678,969Chandrashekhar Pasare · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · AI
Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B
$678,969Chandrashekhar Pasare · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · AI
Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B
$678,969Chandrashekhar Pasare · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · AI
Regulation of TLR signaling, Inflammation and Antigen Presentation by VPS33B
$678,969Chandrashekhar Pasare · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · AI
Neural Plasticity and Inflammatory Pain
$678,963Clifford J Woolf · Boston Children'S Hospital · R37 · FY2016 · NS
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$678,954Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2019 · CA
BIOINFORMATICS CENTER FOR INNATE IMMUNITY PGA
$678,948Brigham And Women'S Hospital · U01 · FY2001 · HL
bZIP proteins, NFAT, and lymphocyte gene induction
$678,945Anjana Rao · La Jolla Institute For Immunology · R01 · FY2014 · AI
NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users
$678,940Luis J. Montaner · Wistar Institute · R01 · FY2012 · DA
The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA methylation in Older African American Women at Risk for Cardiometabolic Disease
$678,879Karen Lynn Saban · Loyola University Chicago · R01 · FY2023 · AG
Molecular Mechanisms of Human Long-lived Plasma Cell Generation in the Bone Marrow and Spleen
$678,860Frances Eun-Hyung Lee · Emory University · U01 · FY2025 · AI
The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis
$678,855Na Li · Baylor College Of Medicine · R01 · FY2022 · HL
Characterization of Mucosal Lymphocytes
$678,846Richard S Blumberg · Brigham And Women'S Hospital · R37 · FY2008 · DK
Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity
$678,736Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2024 · DA
Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity
$678,736Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2022 · DA
Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity
$678,736Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2025 · DA